Literature DB >> 12717627

Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections.

Kevin B Laupland1, Deirdre L Church, Melissa Mucenski, Lloyd R Sutherland, H Dele Davies.   

Abstract

A population-based active-surveillance study of the Calgary Health Region (population, 929,656) was conducted from May 1999 to April 2000, to define the epidemiology of invasive Staphylococcus aureus (ISA) infections. The annual incidence was 28.4 cases/100,000 population; 46% were classified as nosocomial. Infection was most common in people at the extremes of the age spectrum and in males. Several conditions were associated with acquisition of ISA infection, and the highest risk was observed in persons undergoing hemodialysis or peritoneal dialysis and in persons infected with human immunodeficiency virus. Forty-six patients (19%) died. Significant independent risk factors for mortality included positive blood-culture result, respiratory focus, empirical antibiotic therapy, and older age. A higher systolic blood pressure at presentation was associated with reduced case-fatality rate. ISA infections are common, with several definable groups of patients at increased risk for acquisition and death from these infections. This study provides important data on the burden of ISA disease and identifies risk groups that may potentially benefit from preventive efforts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717627     DOI: 10.1086/374621

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  67 in total

1.  Severe MRSA necrotizing pneumonia.

Authors:  S Rasul; F Farhat; S A Asnake
Journal:  Infection       Date:  2012-05-25       Impact factor: 3.553

Review 2.  Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogens.

Authors:  Biswadeep Das; Chayna Sarkar; Debasmita Das; Amit Gupta; Arnav Kalra; Shubham Sahni
Journal:  Ther Adv Infect Dis       Date:  2017-03-08

3.  Risk factors for hospital-acquired methicillin-resistant Staphylococcus aureus bacteraemia: a case-control study.

Authors:  D Carnicer-Pont; K A Bailey; B W Mason; A M Walker; M R Evans; R L Salmon
Journal:  Epidemiol Infect       Date:  2006-04-20       Impact factor: 2.451

Review 4.  Antistaphylococcal vaccines and immunoglobulins: current status and future prospects.

Authors:  Stan Deresinski
Journal:  Drugs       Date:  2006       Impact factor: 9.546

5.  Staphylococcus aureus: The persistent pathogen.

Authors:  B Lynn Johnston; John M Conly
Journal:  Can J Infect Dis       Date:  2003-11

6.  Outcome for invasive Staphylococcus aureus infections.

Authors:  G Jacobsson; E Gustafsson; R Andersson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-01       Impact factor: 3.267

7.  Reduction of methicillin-resistant Staphylococcus aureus infection among veterans in Atlanta.

Authors:  Edward Stenehjem; Cortney Stafford; David Rimland
Journal:  Infect Control Hosp Epidemiol       Date:  2012-11-14       Impact factor: 3.254

8.  Population-based study of the epidemiology and the risk factors for Pseudomonas aeruginosa bloodstream infection.

Authors:  M D Parkins; D B Gregson; J D D Pitout; T Ross; K B Laupland
Journal:  Infection       Date:  2009-12-12       Impact factor: 3.553

9.  Staphylococcus aureus beta-toxin induces lung injury through syndecan-1.

Authors:  Atsuko Hayashida; Allison H Bartlett; Timothy J Foster; Pyong Woo Park
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

10.  Influence of age on behavioral, immune and endocrine responses to the T-cell superantigen staphylococcal enterotoxin A.

Authors:  Rachel A Kohman; Beth Crowell; Daniella Urbach-Ross; Alexander W Kusnecov
Journal:  Eur J Neurosci       Date:  2009-09-24       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.